Schering/J&J's Simponi Gets Positive EU Nod For Approval; J&J Seeks Full Rights To Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J and Schering's Simponi wins positive EU recommendation; meanwhile J&J continues fighting for full rights to the drug and its predecessor Remicade as the Schering/Merck deal unfolds.